Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-01-07 @ 8:08 AM
Study NCT ID:
NCT04165967
Status:
COMPLETED
Last Update Posted:
2024-04-10
First Post:
2019-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2019-01908; me18Laeubli
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |